Dr. Lucy A. Vereshchagina, Ph.D.

Regulatory Scientist

Dr. Lucy Vereshchagina is a regulatory scientist in the FDA/Healthcare Regulation Practice. She provides scientific support on FDA and related regulatory issues pertaining to FDA-regulated products.

Dr. Vereshchagina has an extensive background in biochemistry, chemistry, molecular biology, immunology, microbiology, clinical/regulatory affairs, and drug development. Her areas of expertise include development and management of research projects, drug development processes, preclinical and clinical testing programs, and regulatory submissions for drugs and biologics. She has given numerous presentations at national and international scientific meetings. She has co-authored a number of scientific articles as well as two book chapters on investigational anti-cancer agents.

Prior to joining Morgan Lewis, Dr. Vereshchagina was a clinical/regulatory affairs specialist providing scientific research and regulatory compliance support to the Investigational Drug Branch of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute.

Dr. Vereshchagina earned her Ph.D. in chemistry from The Catholic University of America in 1999 and completed her postdoctoral studies at Walter Reed Army Institute of Research. She received an M.S. in biochemistry from Kazan State University in Russia in 1994.